anti-OLR1 / LOX1 Antibody, 0,1 mg
-
Catalog numberBB-PA1832
-
PricePlease ask
-
Size0,1 mg
-
-
Vial descriptionLOX-1, Ox-LDL receptor 1, Ox-LDL receptor 1 soluble form, sLOX1, sLOX-1, CLEC8A
-
Categoryprimary antibody
-
Raised inRabbit
-
Clone1 vial
-
FormAffinity Purified
-
ReactivityHuman
-
Puritypurified
-
Molecular weightin kDa
-
Sourcemammalian
-
Activityto be determined
-
Rangebroad
-
Protein numberP78380
-
ApplicationWestern Blot
-
StorageShipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
DescriptionThis antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided. Antibody for research use.
-
PropertiesIf you buy Antibodies supplied by acr they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
-
French translationanticorps
-
Gene target
-
Gene symbolOLR1
-
Short nameanti-OLR1 / LOX1 Antibody, 1 mg
-
TechniqueAntibody, anti-, anti, antibody to, antibodies, antibodies against human proteins, antibodies for
-
IsotypeIgG
-
Specieshuman
-
Alternative nameAntibody toOLR1 / LOX1 (antibody to-), 0,1 mg
-
Alternative techniqueantibodies
-
Alternative to gene targetoxidized low density lipoprotein (lectin-like) receptor 1, CLEC8A and LOX1 and LOXIN and SCARE1 and SLOX1, OLR1 and IDBG-18612 and ENSG00000173391 and 4973, carbohydrate binding, nuclei, Olr1 and IDBG-192019 and ENSMUSG00000030162 and 108078, OLR1 and IDBG-639562 and ENSBTAG00000004547 and 281368
-
Gene info
-
Identity
-
Gene
-
Long gene nameoxidized low density lipoprotein receptor 1
-
Synonyms gene name
- oxidised low density lipoprotein (lectin-like) receptor 1
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1998-01-16
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- C-type lectin domain containing
- Scavenger receptors
-
VEGA ID
MeSH Data
-
Name
-
ConceptScope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
-
Tree numbers
- E05.393.220
-
Qualifiersdrug effects, methods, radiation effects